{"cluster": 35, "subcluster": 0, "abstract_summ": "These Airway Chips, which contain human lung epithelial cells that express high levels of ACE2 and TMPRSS2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing SARS-CoV-2 spike protein in human Huh-7 cells, and others recently showed suppress infection by native SARS-CoV-2 in Vero cells.This work suggests that human Organ Chip technology may be used in conjunction with existing rapid cell-based screening assays to study human disease pathogenesis and expedite drug repurposing in biothreat crises caused by pandemic viruses.Several strains of influenza A virus are shown to successfully infect the human primary cell-based airway tissue cultured at an air-liquid interface (ALI), and as a proof-of-concept, the effect of the antiviral oseltamivir on one strain of Influenza A is evaluated.The respiratory Influenza A Viruses (IAVs) and emerging zoonotic viruses such as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pose a significant threat to human health.To accelerate our understanding of the host-pathogen response to respiratory viruses, the use of more complex in vitro systems such as normal human bronchial epithelial (NHBE) cell culture models has gained prominence as an alternative to animal models.", "title_summ": "High-Throughput Human Primary Cell-Based Airway Model for Evaluating Influenza, Coronavirus, or other Respiratory Viruses in vitroSARS-CoV-2 Productively Infects Human Gut EnterocytesTMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytesHuman organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemicsSARS-CoV-2 productively infects human gut enterocytesTMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytesHost-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model.Covid-19, Coronavirus, SARS-CoV-2 and the small bowel.", "title_abstract_phrases": "This work suggests that human Organ Chip technology may be used in conjunction with existing rapid cell-based screening assays to study human disease pathogenesis and expedite drug repurposing in biothreat crises caused by pandemic viruses.Hence, intestinal epithelium supports SARS-CoV-2 replication, and hSIOs serve as an experimental model for coronavirus infection and biologyTMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytesGastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA are frequently observed in COVID-19 patients.Several strains of influenza A virus are shown to successfully infect the human primary cell-based airway tissue cultured at an air-liquid interface (ALI), and as a proof-of-concept, the effect of the antiviral oseltamivir on one strain of Influenza A is evaluated.The respiratory Influenza A Viruses (IAVs) and emerging zoonotic viruses such as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pose a significant threat to human health.One Sentence Summary SARS-CoV-2 infection of enterocytes in human small intestinal organoidsTMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytesBoth gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA have been frequently observed in COVID-19 patients."}